ApprovalTrail

Approval · Notice of Compliance 19223 · 2017

KALYDECO: Notice of Compliance 19223

Issued April 28, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19223
Date
April 28, 2017
Company
Vertex Pharmaceuticals (Canada) IncorporatedToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Additional manufacturing site

Products in this notice

BrandDINStatus today
KALYDECONot yet assigned—

Medicinal ingredients